Press
release from White House Office of National Drug Control Policy, March
7, 2002
FOR
IMMEDIATE RELEASE:
CONTACT: Tom Riley 2023956618
Thursday, March 7, 2002
COCA CULTIVATION
IN COLOMBIA, 2001
(Washington, D.C.)The
annual estimate for coca cultivation in Colombia has been completed. Analysis
of satellite imagery indicates that Colombia's coca cultivation is 169,800
hectares, 33,600 hectares more than 2000 levels. One-third of the increase
is due to the inclusion of an area that was not surveyed in 2000 because
of cloud cover. Also, coca killed by aerial eradication operations conducted
after the satellite photographs were taken was counted as live coca in
the estimate.
Nonetheless, the
increase in cultivation is troubling. The figures underscore the pervasiveness
of cultivation and trafficking in Colombia; the magnitude and complexity
of Colombia's interlocking security, drug control, and economic challenges;
and the need for sustained U.S. engagement. We have a robust assistance
program to Colombia to help meet these challenges, including projects
to support police and military professionalization; eradication, interdiction,
and alternative development; and judicial reform and social and economic
development.
Although the full
complement of counter-drug and development resources is still arriving
in Colombia, we recognize that our efforts to date have not yet produced
the results we had hoped to achieve. The security environment in Colombian
drug cultivation regions has made it difficult to implement counter-drug
programs. We will continue to work with the Government of Colombia to
achieve our mutual objectives of strengthening democracy, eliminating
drug trafficking, and enforcing the rule of law. We also believe that
our renewed effort to drive down the demand for illegal drugs in the United
States will have a beneficial effect on the situation in Colombia. We
will review our strategy to ensure it is effective in the current environment.
As of March 11, 2002,
this document was also available online at http://www.whitehousedrugpolicy.gov/news/press02/030702.html